2-Amino-4-(4-methylsulfanylphenyl)-4H-benzo[h]chromene-3-carbonitrile

ID: ALA4441682

Chembl Id: CHEMBL4441682

PubChem CID: 2840527

Max Phase: Preclinical

Molecular Formula: C21H16N2OS

Molecular Weight: 344.44

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CSc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1

Standard InChI:  InChI=1S/C21H16N2OS/c1-25-15-9-6-14(7-10-15)19-17-11-8-13-4-2-3-5-16(13)20(17)24-21(23)18(19)12-22/h2-11,19H,23H2,1H3

Standard InChI Key:  FJWOJCWFIRKDRZ-UHFFFAOYSA-N

Associated Targets(Human)

518A2 (464 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MYB Tbio Transcriptional activator Myb (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 344.44Molecular Weight (Monoisotopic): 344.0983AlogP: 4.78#Rotatable Bonds: 2
Polar Surface Area: 59.04Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.68CX LogP: 4.65CX LogD: 4.65
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.68Np Likeness Score: -1.12

References

1. Schmitt F, Gold M, Rothemund M, Andronache I, Biersack B, Schobert R, Mueller T..  (2019)  New naphthopyran analogues of LY290181 as potential tumor vascular-disrupting agents.,  163  [PMID:30503940] [10.1016/j.ejmech.2018.11.055]
2. Köhler LHF, Reich S, Yusenko M, Klempnauer KH, Shaikh AH, Ahmed K, Begemann G, Schobert R, Biersack B..  (2022)  A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties.,  13  (11.0): [PMID:36385941] [10.1021/acsmedchemlett.2c00403]

Source